About Frequency Therapeutics
Frequency Therapeutics is a company based in Cambridge (United States) founded in 2015 by Will McLean and Jeffrey Karp. Frequency Therapeutics has raised $136 million across 4 funding rounds from investors including ARE, Korea Investment Holdings and RTW Investments. The company has 48 employees as of February 28, 2023. Frequency Therapeutics operates in a competitive market with competitors including Lyra Therapeutics, QurAlis, Decibel Therapeutics, Perceive Bio and Akouos, among others.
- Headquarter Cambridge, United States
- Employees 48 as on 28 Feb, 2023
- Founders Will McLean, Jeffrey Karp
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$14.07 M (USD)-62as on Dec 31, 2021
-
Net Profit
-$81.58 M (USD)4as on Dec 31, 2022
-
EBITDA
-$83 M (USD)1as on Dec 31, 2022
-
Total Equity Funding
$136 M (USD)
in 4 rounds
-
Latest Funding Round
$42.3 M (USD), Post-IPO
Jul 22, 2020
-
Investors
ARE
& 15 more
-
Employee Count
48
as on Feb 28, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Frequency Therapeutics
Frequency Therapeutics has successfully raised a total of $136M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $42.3 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Frequency Therapeutics
Frequency Therapeutics has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include ARE, Korea Investment Holdings and RTW Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked |
Investor details for Frequency Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Frequency Therapeutics
Investment portfolio details for Frequency Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Frequency Therapeutics
Detailed financials for Frequency Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Frequency Therapeutics Comparisons
Peer comparison for Frequency Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Frequency Therapeutics
Frequency Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyra Therapeutics, QurAlis, Decibel Therapeutics, Perceive Bio and Akouos, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Drugs and CSF devices are developed for ALS treatment.
|
|
| Locked | Locked | Locked |
Medicines are developed to protect, repair, and restore hearing capacity.
|
|
| Locked | Locked | Locked |
Developer of therapeutics to treat diabetes and eye diseases
|
|
| Locked | Locked | Locked |
Developer of gene therapies to restore and preserve hearing capabilities in genetically defined populations
|
|
| Locked | Locked | Locked |
Speciality Pharma company developing novel therapies for inner ear disorders
|
Detailed competitors of Frequency Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Frequency Therapeutics
Complete news archive for Frequency Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Frequency Therapeutics
Frequency Therapeutics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Frequency Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Frequency Therapeutics is a funded company, having raised a total of $136M across 4 funding rounds to date.
As of Feb 28, 2023, the latest employee count at Frequency Therapeutics is 48.
Annual revenue of Frequency Therapeutics is $14.07M as on Dec 31, 2021.
Frequency Therapeutics was founded in 2015 and is headquartered in Cambridge, United States. Operations focus on the biotechnology sector, where small-molecule therapeutics are developed to activate progenitor cells for tissue regeneration. The lead candidate, FX-322, targets sensorineural hearing loss and remyelination in multiple sclerosis. These efforts aim to restore functional tissues using the bodys existing cells.
Frequency Therapeutics's top competitors include Decibel Therapeutics, Lyra Therapeutics and QurAlis.
Frequency Therapeutics has 16 investors. Key investors include ARE, Korea Investment Holdings, RTW Investments, Driehaus, and Perceptive Advisors.